COVID-19 serology test available | Cellex, Inc. qSARS-CoV-2 IgG/IgM Rapid Test Cassette

The Cellex, Inc. qSARS-CoV-2 IgG/IgM Rapid Test, which has received an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA), is indicated for the qualitative detection and differentiation of IgM and IgG antibodies against SARS-CoV-2 in serum, plasma (EDTA or citrate), or venipuncture whole blood from individuals suspected of COVID-19 by a healthcare provider. Emergency use of this test is limited to authorized laboratories.